Dr. Kimberly L Dodge-Kafka's lab at the University of Connecticut focuses on understanding how specific calcium signaling pathways contribute to heart conditions, particularly cardiac hypertrophy. The lab is investigating how calcium microdomains affect signaling in heart cells and aims to develop new treatments for heart disease by targeting these pathways. Their research emphasizes the role of certain protein complexes in regulating calcium signals that can lead to heart remodeling and failure.

Dr. Elsio Augusto Wunder's lab at the University of Connecticut focuses on developing a universal vaccine for leptospirosis, an infectious disease that affects both humans and animals. The lab is particularly interested in identifying protective immune responses against various strains of the disease-causing bacteria, Leptospira spp. They aim to create a vaccine that can effectively prevent this neglected tropical disease, which poses significant health risks in both developing and urban populations.

Dr. Lixia Yue's lab at the University of Connecticut focuses on understanding the mechanisms behind cardiac fibrosis, a condition that contributes to various heart diseases. By investigating a specific ion channel called TRPM7 in cardiac fibroblasts, the lab aims to explore therapeutic targets for improving treatment options for heart failure. The research combines molecular biology with advanced animal models to uncover how signaling pathways influence heart health.